Profile data is unavailable for this security.
About the company
MDxHealth SA is a Belgium-based healthcare company which provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The Company’s tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, as well as prediction of response to a specific therapy. Its tests include ConfirmMDx for Prostate Cancer, SelectMDx for Prostate Cancer, PredictMDx for Glioblastoma and AssureMDx for Bladder Cancer. The Company's corporate operations are based in Herstal, Belgium, as well as Irvine, the United States, and its laboratory operations are based in Nijmegen, the Netherlands, as well as Irvine, the United States.
- Revenue in USD (TTM)103.07m
- Net income in USD-31.43m
- Incorporated2003
- Employees312.00
- LocationMDxHealth SACAP Business Center, Rue d'Abhooz 31HERSTAL 4040BelgiumBEL
- Phone+32 43642070
- Fax+32 42597875
- Websitehttps://mdxhealth.com/
More ▼
Mergers & acquisitions
| Acquired company | MDXH:NAQ since announced | Transaction value |
|---|---|---|
| Exosome Diagnostics Inc | 37.65% | 15.00m |
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ProQR Therapeutics NV | 19.08m | -50.52m | 153.80m | 166.00 | -- | 2.32 | -- | 8.06 | -0.4858 | -0.4858 | 0.1837 | 0.6288 | 0.139 | -- | 9.70 | 114,910.10 | -36.82 | -29.87 | -53.74 | -35.27 | -- | -- | -264.83 | -501.81 | -- | -- | 0.2242 | -- | 105.20 | 58.84 | 1.27 | -- | 19.58 | -- |
| Eledon Pharmaceuticals Inc | 0.00 | -10.27m | 160.06m | 31.00 | -- | 3.42 | -- | -- | -0.0993 | -0.0993 | 0.00 | 1.52 | 0.00 | -- | -- | 0.00 | -65.28 | -46.29 | -73.32 | -48.06 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 68.95 | -- | -- | -- |
| Kalaris Therapeutics Inc | 0.00 | -51.71m | 161.78m | 6.00 | -- | 3.86 | -- | -- | -87.38 | -87.38 | 0.00 | 2.24 | 0.00 | -- | -- | 0.00 | -50.77 | -52.59 | -52.70 | -57.65 | -- | -- | -- | -- | -- | -- | 0.4338 | -- | -- | -- | 69.14 | -- | -- | -- |
| Sagimet Biosciences Inc | 0.00 | -57.67m | 164.56m | 14.00 | -- | 1.38 | -- | -- | -1.79 | -1.79 | 0.00 | 3.67 | 0.00 | -- | -- | 0.00 | -38.04 | -40.69 | -39.78 | -43.01 | -- | -- | -- | -6,987.70 | -- | -- | 0.00 | -- | -100.00 | -- | -63.46 | -- | -- | -- |
| MDxHealth SA | 103.07m | -31.43m | 168.29m | 312.00 | -- | -- | -- | 1.63 | -0.7275 | -0.7275 | 2.21 | -0.1669 | 0.6614 | 7.00 | 6.20 | 330,349.30 | -20.17 | -40.27 | -29.24 | -50.75 | 64.48 | 57.38 | -30.50 | -76.84 | 1.02 | -0.8112 | 1.10 | -- | 28.29 | 50.19 | 11.67 | -- | 96.87 | -- |
| Tharimmune Inc | 0.00 | -10.32m | 169.03m | 2.00 | -- | 5.25 | -- | -- | -4.11 | -4.11 | 0.00 | 0.854 | 0.00 | -- | -- | 0.00 | -159.36 | -169.40 | -225.01 | -410.04 | -- | -- | -- | -- | -- | -- | 0.0255 | -- | -- | -- | -30.89 | -- | -- | -- |
| Cartesian Therapeutics Inc | 1.93m | -50.61m | 169.54m | 66.00 | -- | -- | -- | 87.98 | -1.97 | -1.97 | 0.0743 | -1.38 | 0.0047 | -- | 0.6943 | 29,196.97 | -11.59 | -33.50 | -12.10 | -45.25 | -- | -- | -2,489.83 | -128.46 | -- | -- | -- | -- | 49.64 | 42.27 | 69.90 | -- | 186.63 | -- |
| Editas Medicine Inc | 46.38m | -199.84m | 171.81m | 246.00 | -- | 12.20 | -- | 3.70 | -2.38 | -2.38 | 0.5454 | 0.1443 | 0.1753 | -- | 11.24 | 188,548.80 | -75.51 | -34.19 | -101.13 | -38.43 | -- | -- | -430.84 | -373.02 | -- | -- | 0.8145 | -- | -58.64 | 9.50 | -54.74 | -- | 7.43 | -- |
| Zentalis Pharmaceuticals Inc | 26.87m | -149.32m | 172.68m | 166.00 | -- | 0.6828 | -- | 6.43 | -2.08 | -2.08 | 0.3743 | 3.50 | 0.0691 | -- | -- | 161,837.30 | -38.39 | -43.59 | -43.54 | -49.56 | -- | -- | -555.80 | -1,402.74 | -- | -- | 0.00 | -- | -- | -- | 43.24 | -- | -8.89 | -- |
| Tiziana Life Sciences Ltd - ADR | 0.00 | -12.84m | 174.99m | 8.00 | -- | 17.95 | -- | -- | -0.1136 | -0.1136 | 0.00 | 0.0774 | 0.00 | -- | -- | 0.00 | -93.18 | -57.21 | -231.54 | -73.22 | -- | -- | -- | -- | -- | -- | 0.0115 | -- | -- | -- | 32.94 | -- | 37.77 | -- |
| Galectin Therapeutics Inc | 0.00 | -37.44m | 177.94m | 15.00 | -- | -- | -- | -- | -0.5913 | -0.5913 | 0.00 | -1.92 | 0.00 | -- | -- | 0.00 | -178.33 | -117.54 | -- | -197.34 | -- | -- | -- | -- | -- | -3.57 | -- | -- | -- | -- | -5.35 | -- | -- | -- |
| C4 Therapeutics Inc | 30.11m | -119.08m | 183.17m | 110.00 | -- | 0.9079 | -- | 6.08 | -1.67 | -1.67 | 0.4225 | 2.08 | 0.0939 | -- | 3.57 | 273,709.10 | -37.12 | -26.50 | -42.35 | -29.90 | -- | -- | -395.51 | -310.19 | -- | -- | 0.00 | -- | 71.44 | 10.72 | 20.51 | -- | -33.16 | -- |
| SAB Biotherapeutics Inc | 114.70k | -21.37m | 183.29m | 63.00 | -- | 1.11 | 8.34 | 1,597.96 | -2.81 | -2.81 | 0.0043 | 3.48 | 0.001 | -- | 0.3492 | 1,820.64 | 15.80 | -- | 17.22 | -- | -- | -- | 16,338.04 | -- | -- | -- | 0.0197 | -- | -40.94 | -- | 19.17 | -- | -- | -- |
Data as of Feb 13 2026. Currency figures normalised to MDxHealth SA's reporting currency: US Dollar USD
34.22%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Bleichroeder LPas of 30 Sep 2025 | 7.38m | 14.91% |
| AWM Investment Co., Inc.as of 30 Sep 2025 | 5.22m | 10.55% |
| Samjo Management LLCas of 30 Sep 2025 | 1.45m | 2.92% |
| Perkins Capital Management, Inc.as of 31 Dec 2025 | 1.38m | 2.79% |
| Kennedy Capital Management LLCas of 30 Sep 2025 | 392.65k | 0.79% |
| Northern Trust Global Investments Ltd.as of 30 Sep 2025 | 305.07k | 0.62% |
| FreeGulliver LLCas of 30 Sep 2025 | 252.89k | 0.51% |
| Renaissance Technologies LLCas of 30 Sep 2025 | 202.80k | 0.41% |
| Northern Trust Investments, Inc.(Investment Management)as of 30 Sep 2025 | 202.54k | 0.41% |
| Mink Brook Asset Management LLCas of 30 Sep 2025 | 159.73k | 0.32% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
